Metshine-GP 1 Tablet ER
Marketer
Alexa Organics Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metshine-GP 1 Tablet ER
GlucoBalance XR, a single-strength extended-release tablet, combines medications to manage blood glucose. Used alongside diet and exercise, it improves glycemic control in adults with type 2 diabetes by enhancing insulin effectiveness, thus reducing blood sugar. Always follow your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume your regular schedule. Never double the dose; overdose can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; monitor blood sugar levels closely. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption, as it may heighten the risk of adverse events.
Primary Ingredients of Metshine-GP 1 Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Metshine-GP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Metshine-GP 1 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Metshine-GP 1 Tablet ER with a meal.
Common Side effects of Metshine-GP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metshine-GP 1 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet whole; avoid chewing, crushing, or breaking it. Consume Metshine-GP 1 Tablet ER with a meal.
How Metshine-GP 1 Tablet ER works:
Metshine-GP 1 Extended-Release tablet combines the actions of three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple therapy offers enhanced blood glucose management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity in the body.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metshine-GP 1 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Metshine-GP 1 Tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metshine-GP tablets (1 mg) are likely not safe for use while breastfeeding. Available evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Metshine-GP 1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting severe kidney disease, Metshine-GP 1 Tablet ER is contraindicated. Close monitoring of kidney function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Metshine-GP 1 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Metshine-GP 1 Tablet ER is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Metshine-GP 1 Tablet ER :
Should you forget a Metshine-GP 1 Tablet ER dose, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metshine-GP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently